Biomedical research is our strongest tool for preventing and curing the
serious illnesses that affect our population. I have, therefore, always been a
strong advocate for expanding the federal support of biomedical research within
the National Institutes of Health (NIH) and other government agencies. Enabling
researchers to develop cures and more effective remedies for such diseases as
cancer, HIV/AIDS, and Parkinson's is an important way to reach our goal of
advancing health care and making medical innovation more widely available and
affordable to the public. Numerous
debilitating diseases affect millions of Americans each year and cost our
country dearly in the way of human suffering. For this reason, I supported a
Sense of the Senate Amendment in 1997 that doubled the budget of the NIH over a
period of five years. I also supported a $3 billion increase in funding for the
NIH for the 2002 fiscal year (FY), setting total funding for the NIH at $23.3
billion. Additionally, I am pleased that the President's proposed FY 2003 budget
keeps our promise to double the NIH budget over five years, raising it from
$13.6 billion in 1998 to $27.2 billion in 2003. I am committed to working
tirelessly to protect NIH funding and its ability to develop new cures, giving
new hope to those Americans suffering from chronic and fatal illnesses.
Few policy
issues in recent memory have occasioned greater moral and ethical debate than
the issues of embryonic stem cell research and "therapeutic" cloning. Sincere
and thoughtful voices have weighed in on both sides of the discussion; some tout
the scientific advances such research may provide, others raise objections that
no advances can justify the destruction of young human life. I have consistently
and proudly been an advocate for the sanctity of all human life throughout this
debate.
The National Institutes of Health (NIH) is an agency of the Department
of Health and Human Services (HHS) and the focal point for biomedical research
funded by the federal government. The NIH plays a crucial role in supporting
basic and clinical research and development programs at leading research
institutions worldwide. I champion this public/private research partnership,
which has allowed the United States to maintain its position as the world leader
in medical technology.
The NIH is comprised of 17 biomedical research
institutes and centers, each focusing on particular illnesses or internal
systems of the body. Among these 17 organizations are:
The National Cancer Institute (NCI)
The National Heart, Lung, and Blood Institute (NHLBI)
The National Institute of Diabetes and Digestive and Kidney
Diseases (NIDDK)
The National Institute of Arthritis and Muscoskeletal and Skin
Diseases (NIAMS)
The National Eye Institute (NEI)
Visit the NIH
website to learn more about the NIH and its progams.
For a complete list of NIH agencies
and offices, click here.
Cancer
There are few among us without a close
relative, loved one, or friend who has been afflicted by this terrible disease.
I am working with my colleagues in Congress to reduce mortality rates for all
types of cancer, and to improve the quality of life for patients undergoing
cancer treatments. The most effective way of doing this is ensuring that the
government spends sizeable resources on biomedical research, so that we can
understand more about the pathology of the disease and study the efficacy of
cancer treatments.
I have long supported the efforts of the
National Cancer Institute (NCI), a research institute within
the NIH that conducts and supports basic applied research in cancer prevention,
early detection, diagnosis, treatment, and rehabilitation. The NCI also provides
training support for research scientists, clinicians, and educators, and
maintains a national network of cancer centers, clinical cooperative groups,
community oncology programs, and outreach programs. In fiscal year (FY) 2002,
Congress appropriated $4.19 billion for the NCI, and I am pleased that the
President's proposed FY 2003 budget increases NCI funding by another $501.4
million. The government has also funded cancer research programs within the
Department of Defense (DoD) to conduct important research into the causes of and
potential cures for prostate, breast, and ovarian cancers. I approved of
appropriations for this purpose.
In 1997, I was a cosponsor of
legislation to create a special postage stamp raising money for breast cancer
research. This fundraising mechanism, which was implemented in 1998, has been
extremely successful. By allowing Americans to purchase these special breast
cancer research stamps at a cost above the standard rate for first class
postage, this program provides NIH and the DoD breast cancer research programs
with an essential source of funding. In 2001, I cosponsored legislation to
reauthorize this important program through 2003, an effort that was ultimately
successful. Lastly, I also cosponsored the Breast and Cervical Cancer
Prevention and Treatment Act, which would have provided additional
Medicaid funding to the states to treat lower-income women who have been
diagnosed with these cancers.
Cancer is a disease that does not
differentiate between gender, race, or geography. It is a disease against which
all Americans must stand united. I remain confident that with strong federal
policies to encourage increased biomedical research and the widespread
availability of cancer treatments, it is truly a threat that we can eliminate in
this new century.
According to a report by the
Centers for Disease Control and Prevention (CDC), cases of Lyme Disease in
Pennsylvania ranked fourth highest in the nation between 1990 and 1999. Lyme
Disease is an illness spread by deer ticks that initially affects the skin. If
left untreated, the disease can spread to the joints, nervous system, and other
organs. Though most cases can be successfully treated with antibiotics if caught
early enough, some long-lasting symptoms, such as persistent arthritis or nerve
abnormalities, do rarely occur.
There is currently no reliable
diagnostic tests for chronic Lyme Disease, making diagnosis and treatment very
challenging for physicians. Lyme Disease research has directly benefitted from
Congress's efforts to increase funding at the National Institutes of Health, but
a lack of coordination and proper funding at the CDC have left many questions
unanswered.
For these reasons, I am proud to be an original cosponsor of
Lyme and Infectious Disease Information and Fairness in Treatment
(LIIFT) Act. The LIIFT Act will establish a two-year public health
management plan authorizing $43 million to improve the diagnostic detection, and
reduce the prevalence, of Lyme Disease. This legislation will also establish a
Tick-borne Advisory Committee within the Department of Health and Human Services
in order to coordinate current and future funding efforts and develop concrete
policy goals for addressing Lyme Disease and other tick-borne illnesses. The
Committee's membership, representing scientists, clinicians, non-profit
organizations, and the public will give a voice to Lyme Disease patients who are
often unheard.
I will continue to work in Congress to help those at risk
for Lyme Disease, but I urge all Pennsylvanians to be especially vigilant during
periods of warmer weather. Studies show that it usually takes 36 to 48 hours for
a tick to actually transmit Lyme Disease, which is why it is so important for
people who have been outdoors in the yard or the woods to check themselves
regularly for ticks or tick bites, and seek medical attention if necessary.
To learn more about Lyme
Disease, check out the following websites:
The National Institutes of Health Lyme Disease
information
Lyme Disease Foundation, Inc.
American Lyme Disease Foundation, Inc.
When President Bush announced his decision on federal funding
for embryonic stem cell research, he did his best on this very difficult issue
to defend and support human life, while also advancing medical science to help
those with debilitating diseases. Despite the fact that he put together the best
possible compromise, I do not think this is an area for compromise. I agree more
with the President's statement on human cloning – that it is not acceptable
under any circumstances. Though no federal funds will go for the actual
destruction of human life, under President Bush's plan, research will benefit
from the previous destruction of human life, and that is not something I can
support. I must respectfully disagree with any taxpayer funding for embryonic
stem cell research.
I recently joined my colleague, Senator John Ensign,
to introduce the Responsible Stem Cell Research Act. Our bill
would increase funding for adult stem cell research by $275 million next year,
approximately 50 percent above the current level. This legislation would also
establish a National Stem Cell Donor Bank, to generate a source of adult stem
cells which would be available for treatment, biomedical research, and other
clinical purposes. Our bill aggressively funds and develops promising medical
research without relying on harvested embryonic stem cells. In addition to the
Ensign bill, I proudly cosponsored the Human Cloning Prohibition
Act. I believe that the cloning of human embryos is simply morally
unacceptable, and I support this legislation that would prohibit any person or
organization from cloning human embryos through somatic cell transfer
techniques. Violators would be subject to a fine and up to ten years'
imprisonment.
While I support the advancement of science, I have many
reservations and concerns regarding research upon, and the cloning of, human
embryos, especially when the alternative of adult stem cell research is widely
seen as promising and morally acceptable. I will do my best to make sure that
our government strongly supports the promise of medical discovery, while
ensuring that it will not violate or degrade the value of human life.
More
Health Care Information:
Quality
of Care
Access
to Care
Health Care
Home
United States Senate | 511 Dirksen Senate Office Building |
Washington DC | 20510 | Phone: (202) 224-6324